OrbiMed’s LifePoint Health, Inc. LPNT Stock Holding History

OrbiMed’s Portfolio LPNT Stock Details LPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-513,200	Closed	-$25M	–	170
2018 Q2	$25M	Sell	513,200 -389,625	-43%	-$20.2M	0.3%	74
2018 Q1	$42.4M	Buy	+902,825	New	+$43.4M	0.53%	55

Other funds holding LPNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

OrbiMed's LPNT Position: Q3 2018 in Review

OrbiMed sold out of LifePoint Health, Inc. (LPNT) in Q3 2018, closing a stake of 513,200 shares — an estimated $25M sold.

OrbiMed first reported a position in LPNT in Q1 2018 and held it in 2 quarters. The position peaked at $42.4M in Q1 2018. 223 funds tracked by Wall St. Rank hold LPNT as of Q3 2018.

OrbiMed reported no remaining LifePoint Health, Inc. position as of Q3 2018 after selling out during the quarter.
OrbiMed sold 513,200 LifePoint Health, Inc. shares in Q3 2018, an estimated $25M.
OrbiMed first reported a position in LifePoint Health, Inc. in Q1 2018 and held it in 2 quarters.
OrbiMed's LifePoint Health, Inc. position peaked at $42.4M in Q1 2018.
223 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q3 2018.

Based on OrbiMed's 13F filing for Q3 2018, filed 14 Nov 2018.